Project Details
Short title | Amendment for the National Lung Matrix Trial: Multi-drug, genetic marker-directed, non-comparative, multi-centre, multi-arm phase II trial in non-small cell lung cancer |
---|---|
Status | Finished |
Effective start/end date | 1/10/17 → 31/03/19 |
Funding
- Cancer Research Uk